1. Home
  2. XLO vs RGS Comparison

XLO vs RGS Comparison

Compare XLO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • RGS
  • Stock Information
  • Founded
  • XLO 2016
  • RGS 1922
  • Country
  • XLO United States
  • RGS United States
  • Employees
  • XLO N/A
  • RGS N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • XLO Health Care
  • RGS Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • RGS Nasdaq
  • Market Cap
  • XLO 37.9M
  • RGS 44.6M
  • IPO Year
  • XLO 2021
  • RGS 1991
  • Fundamental
  • Price
  • XLO $0.75
  • RGS $16.99
  • Analyst Decision
  • XLO Buy
  • RGS
  • Analyst Count
  • XLO 1
  • RGS 0
  • Target Price
  • XLO $4.00
  • RGS N/A
  • AVG Volume (30 Days)
  • XLO 233.4K
  • RGS 13.5K
  • Earning Date
  • XLO 05-13-2025
  • RGS 04-30-2025
  • Dividend Yield
  • XLO N/A
  • RGS N/A
  • EPS Growth
  • XLO N/A
  • RGS N/A
  • EPS
  • XLO N/A
  • RGS 40.46
  • Revenue
  • XLO $6,344,000.00
  • RGS $191,336,000.00
  • Revenue This Year
  • XLO $668.96
  • RGS N/A
  • Revenue Next Year
  • XLO $14.49
  • RGS N/A
  • P/E Ratio
  • XLO N/A
  • RGS $0.46
  • Revenue Growth
  • XLO N/A
  • RGS N/A
  • 52 Week Low
  • XLO $0.62
  • RGS $3.87
  • 52 Week High
  • XLO $1.70
  • RGS $35.50
  • Technical
  • Relative Strength Index (RSI)
  • XLO 50.44
  • RGS 44.51
  • Support Level
  • XLO $0.63
  • RGS $15.75
  • Resistance Level
  • XLO $0.80
  • RGS $17.81
  • Average True Range (ATR)
  • XLO 0.06
  • RGS 1.41
  • MACD
  • XLO 0.01
  • RGS 0.14
  • Stochastic Oscillator
  • XLO 72.93
  • RGS 47.04

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About RGS Regis Corporation

Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.

Share on Social Networks: